InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by George Kemble. Director active across 2 companies, notably SAGIMET BIOSCIENCES INC. In total, 3 disclosures have been published. History available since 20 July 2026. The latest transaction was filed on 14 August 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条